Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126562263 | 12656226 | 3 | F | 20160616 | 20160830 | 20160816 | 20160915 | EXP | DE-CELGENEUS-DEU-2016072248 | CELGENE | 74.00 | YR | M | Y | 0.00000 | 20160915 | OT | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126562263 | 12656226 | 1 | PS | AZACITIDINE INJECTABLE | AZACITIDINE | 1 | Subcutaneous | 139.5 MILLIGRAM | U | 50794 | 139.5 | MG | INJECTION | QD | |||||
| 126562263 | 12656226 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous drip | U | 0 | 1890 | MG | UNKNOWN | QD | ||||||
| 126562263 | 12656226 | 3 | SS | MITOXANTRONE | MITOXANTRONE HYDROCHLORIDE | 1 | Intravenous drip | 1890 MILLIGRAM | U | 0 | 118.9 | MG | UNKNOWN | QD | |||||
| 126562263 | 12656226 | 4 | C | Avalox | MOXIFLOXACIN HYDROCHLORIDE | 1 | Unknown | 118.9 MILLIGRAM | 0 | UNKNOWN | |||||||||
| 126562263 | 12656226 | 5 | C | Fortum | CEFTAZIDIME | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126562263 | 12656226 | 6 | C | TYGACIL | TIGECYCLINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126562263 | 12656226 | 7 | C | VFEND | VORICONAZOLE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126562263 | 12656226 | 1 | Acute myeloid leukaemia |
| 126562263 | 12656226 | 2 | Acute myeloid leukaemia |
| 126562263 | 12656226 | 3 | Acute myeloid leukaemia |
| 126562263 | 12656226 | 4 | Product used for unknown indication |
| 126562263 | 12656226 | 5 | Product used for unknown indication |
| 126562263 | 12656226 | 6 | Product used for unknown indication |
| 126562263 | 12656226 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126562263 | 12656226 | HO |
| 126562263 | 12656226 | LT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126562263 | 12656226 | Pneumonia | |
| 126562263 | 12656226 | Urosepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126562263 | 12656226 | 1 | 20160520 | 20160526 | 0 | |
| 126562263 | 12656226 | 2 | 20160610 | 20160616 | 0 | |
| 126562263 | 12656226 | 3 | 20160610 | 20160612 | 0 |